Compare · CDIO vs LMDX
CDIO vs LMDX
Side-by-side comparison of Cardio Diagnostics Holdings Inc. (CDIO) and LumiraDx Limited (LMDX): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CDIO and LMDX operate in Biotechnology: In Vitro & In Vivo Diagnostic Substances (Health Care), so they compete in similar markets.
- LMDX is the larger of the two at $2.23B, about 486.4x CDIO ($4.6M).
- CDIO has hit the wire 5 times in the past 4 weeks while LMDX has been quiet.
- LMDX has more recent analyst coverage (4 ratings vs 0 for CDIO).
- Company
- Cardio Diagnostics Holdings Inc.
- LumiraDx Limited
- Price
- $1.57-2.48%
- $0.02-53.80%
- Market cap
- $4.6M
- $2.23B
- 1M return
- -22.28%
- -
- 1Y return
- -64.40%
- -
- Industry
- Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2022
- News (4w)
- 5
- 0
- Recent ratings
- 0
- 4
Latest CDIO
- SEC Form PRE 14A filed by Cardio Diagnostics Holdings Inc.
- SEC Form 4 filed by Director Fung Peter K
- SEC Form 4 filed by Director Betts Wendy J
- SEC Form 4 filed by Director Intrater James
- SEC Form 4 filed by Director Burton Paul Frederick
- Atlas Healthcare Physicians to Cover Cardio Diagnostics’ Precision Cardiovascular Medicine Tests Across Its Network
- Cardio Diagnostics Holdings, Inc. to Showcase Precision Cardiovascular Solutions at Four National Benefits Conferences in June
- IBN Announces Latest Episode of The BioMedWire Podcast Featuring Dr. Meesha Dogan, CEO of Cardio Diagnostics Holdings Inc.
- SEC Form 10-Q filed by Cardio Diagnostics Holdings Inc.
- IBN Initiates Coverage of Cardio Diagnostics Holdings Inc.
Latest LMDX
- SEC Form SC 13G/A filed by LumiraDx Limited (Amendment)
- SEC Form SC 13G/A filed by LumiraDx Limited (Amendment)
- SEC Form 6-K filed by LumiraDx Limited
- 12 Health Care Stocks Moving In Monday's After-Market Session
- Dow Surges Over 100 Points; Commercial Metals Posts Upbeat Q1 Results
- Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
- LumiraDx shares are trading lower after the company announced its securities will be suspended from trading on Nasdaq at the open of business tomorrow.
- 12 Health Care Stocks Moving In Monday's Intraday Session
- Crude Oil Falls Sharply; Ambrx Biopharma Shares Spike Higher
- US Stocks Mixed; Nasdaq Jumps Over 100 Points